N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide
C30H32ClFN2O3 — CID 125010566
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide
N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide (PubChem CID 125010566) has the molecular formula C30H32ClFN2O3 and a molecular weight of 523.05 g/mol. Its IUPAC name is N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide.
Molecular Properties
| Compound Name | N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide |
|---|---|
| PubChem CID | 125010566 |
| Molecular Formula | C30H32ClFN2O3 |
| Molecular Weight | 523.05 g/mol |
| Exact Mass | 522.21 |
| IUPAC Name | N-benzyl-2-[(3R)-3-[(3-chlorophenoxy)methyl]-1-(3-fluoro-4-methylbenzoyl)piperidin-3-yl]-N-methylacetamide |
| SMILES | Cc1ccc(C(=O)N2CCC[C@@](COc3cccc(Cl)c3)(CC(=O)N(C)Cc3ccccc3)C2)cc1F |
| InChI | InChI=1S/C30H32ClFN2O3/c1-22-12-13-24(16-27(22)32)29(36)34-15-7-14-30(20-34,21-37-26-11-6-10-25(31)17-26)18-28(35)33(2)19-23-8-4-3-5-9-23/h3-6,8-13,16-17H,7,14-15,18-21H2,1-2H3/t30-/m1/s1 |
| InChIKey | VKGDHPDWLQUGQJ-SSEXGKCCSA-N |
| XLogP | 6.14 |
| TPSA | 49.85 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 523.05 |
| LogP ≤ 5 | 6.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 125010566 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.